Restricted accessResearch articleFirst published online 2026-4
“They Never,Never,Never Give Up on Me”: Perspectives on an Addiction Consult Service From Hospitalized People Who Use Opioids at 6 New York City Public Hospitals
Lifesaving medications for opioid use disorder (MOUD) exist; however, most people with opioid use disorder (OUD) do not receive treatment. Hospitalization is one important opportunity to engage people with OUD and offer treatment, including MOUD. Between 2018 and 2020, 6 public hospitals in New York City launched the “Consult for Addiction Treatment and Care in Hospitals” (CATCH) program to provide interprofessional addiction consult services to hospitalized patients.
Methods:
This qualitative study aims to add perspectives from 30 racially and ethnically diverse people with opioid-related diagnoses who were hospitalized at a CATCH hospital between October 2019 and April 2021. We used purposive sampling to recruit demographically diverse individuals who accepted or declined aspects of CATCH services. Interviews were audio-recorded, transcribed, and coded for emergent themes using grounded theory techniques. The framework of structural vulnerability was utilized to highlight how social context impacts patients’ experiences of healthcare, and in turn affects their addiction trajectories.
Results:
Participants overwhelmingly accepted MOUD to manage withdrawal symptoms during hospitalization, and many planned to continue MOUD after discharge. Participants appreciated the interprofessional support of CATCH teams which included medical providers, social workers, addiction counselors, and peers. While participants felt that CATCH made holistic addiction treatment including MOUD more accessible, structural issues created barriers to continuing treatment long term. Some participants still felt stigmatized or “punished” for their drug use by non-CATCH providers.
Conclusion:
CATCH met an urgent need for nonjudgmental care and medical management of opioid withdrawal. Additional interventions that address broader needs, including housing and social supports, as well as trust-building healthcare encounters for patients who have been historically marginalized, are needed to meet the public health goal of preventing overdose and reducing drug-related morbidity for this population.
KrawczykNRiveraBDJentVKeyesKMJonesCMCerdaM.Has the treatment gap for opioid use disorder narrowed in the U.S.?: a yearly assessment from 2010 to 2019. Int J Drug Policy. 2022;110:103786. doi:10.1016/j.drugpo.2022.103786
3.
JonesCMHanBBaldwinGTEinsteinEBComptonWM.Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021. JAMA Netw Open. 2023;6(8):e2327488. doi:10.1001/jamanetworkopen.2023.27488
4.
KrawczykNFederKAFingerhoodMISalonerB.Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample. Drug Alcohol Depend. 2017;178:512-518. doi:10.1016/j.drugalcdep.2017.06.009
5.
NguyenTZiedanESimonK, et al. Racial and ethnic disparities in buprenorphine and extended-release naltrexone filled prescriptions during the COVID-19 pandemic. JAMA Netw Open. 2022;5(6):e2214765. doi:10.1001/jamanetworkopen.2022.14765
6.
KariisaMDavisNLKumarS, et al. Drug overdose deaths, by selected sociodemographic and social determinants of health characteristics—25 states and the District of Columbia, 2019-2020. MMWR Morb Mortal Wkly Rep. 2022;71(29):940-947.
7.
EnglanderHDavisCS.Hospital standards of care for people with substance use disorder. N Engl J Med. 2022;387(8):672-675. doi:10.1056/NEJMp2204687
8.
SuenLWMakamANSnyderHR, et al. National prevalence of alcohol and other substance use disorders among emergency department visits and hospitalizations: NHAMCS 2014-2018. J Gen Intern Med. 2022;37(10):2420-2428. doi:10.1007/s11606-021-07069-w
9.
KingCCookRKorthuisPTMorrisCDEnglanderH.Causes of death in the 12 months after hospital discharge among patients with opioid use disorder. J Addict Med. 2022;16(4):466-469. doi:10.1097/ADM.0000000000000915
10.
EnglanderHCollinsDPerrySPRabinowitzMPhoutridesENicolaidisC.“We’ve learned it’s a medical illness, not a moral choice”: qualitative study of the effects of a multicomponent addiction intervention on hospital providers’ attitudes and experiences. J Hosp Med. 2018;13(11):752-758. doi:10.12788/jhm.2993
11.
VelezCMNicolaidisCKorthuisPTEnglanderH.“It’s been an experience, a life learning experience”: a qualitative study of hospitalized patients with substance use disorders. J Gen Intern Med. 2017;32(3):296-303. doi:10.1007/s11606-016-3919-4
12.
BabbelDMLiuPChenDR, et al. Inpatient opioid withdrawal: a qualitative study of the patient perspective. Intern Emerg Med. 2024;19(5):1291-1298. doi:10.1007/s11739-024-03604-9
JakubowskiASingh-TanSTorres-LockhartK, et al. Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. Addict Sci Clin Pract. 2023;18(1):31. doi:10.1186/s13722-023-00386-x
15.
CioeKBiondiBEEaslyRSimardAZhengXSpringerSA.A systematic review of patients’ and providers’ perspectives of medications for treatment of opioid use disorder. J Subst Abuse Treat. 2020;119:108146. doi:10.1016/j.jsat.2020.108146
16.
DanovitchIKorouriSKaurH, et al. The addiction consultation service for hospitalized patients with substance use disorder: an integrative review of the evidence. J Subst Use Addict Treat. 2024;163:209377. doi:10.1016/j.josat.2024.209377
17.
RodgerLCyglerJPintoA.Quantitative and qualitative outcomes associated with inpatient addiction consultation: a scoping review. Am J Drug Alcohol Abuse. 2024;50(5):587-618. doi:10.1080/00952990.2024.2350696
18.
EnglanderHJonesAKrawczykN, et al. A Taxonomy of hospital-based addiction care models: a scoping review and key informant interviews. J Gen Intern Med. 2022;37(11):2821-2833. doi:10.1007/s11606-022-07618-x
19.
BahjiABrothersTDMauer-VakilD, et al. The effectiveness of inpatient addiction consult services: a systematic review and narrative synthesis. Can J Addict. 2023;14(2):9-19.
20.
WeimerMMorfordKDonroeJ.Treatment of opioid use disorder in the acute hospital setting: a critical review of the literature (2014-2019). Curr Addict Rep. 2019;6(4):339-354. doi:10.1007/s40429-019-00267-x
21.
CollinsDAllaJNicolaidisC, et al. “If it wasn’t for him, I wouldn’t have talked to them”: qualitative study of addiction peer mentorship in the hospital. J Gen Intern Med. 2019;12:12. doi:10.1007/s11606-019-05311-0
22.
HyshkaEMorrisHAnderson-BaronJNixonLDongKSalvalaggioG.Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital. Drug Alcohol Depend. 2019;204:107523.
23.
CalcaterraSLLockhartSCallisterCHooverKBinswangerIA.Opioid use disorder treatment initiation and continuation: a qualitative study of patients who received addiction consultation and hospital-based providers. J Gen Intern Med. 2022;37(11):2786-2794. doi:10.1007/s11606-021-07305-3
24.
HooverKLockhartSCallisterCHoltropJSCalcaterraSL.Experiences of stigma in hospitals with addiction consultation services: a qualitative analysis of patients’ and hospital-based providers’ perspectives. J Subst Abuse Treat. 2022;138:108708. doi:10.1016/j.jsat.2021.108708
25.
KingCCollinsDPattenANicolaidisCEnglanderH.Trust in hospital physicians among patients with substance use disorder referred to an addiction consult service: a mixed-methods study. J Addict Med. 2022;16(1):41-48. doi:10.1097/ADM.0000000000000819
NYC Office of Chief Medical Examiner and NYC DOHMH Bureau of Vital Statistics. Unintentional Drug Poisoning (Overdose) Deaths in New York City in 2022. New York City Department of Health and Mental Hygiene: Epi Data Brief (#137); September 2023.
28.
RhodesT.Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193-201. doi:10.1016/j.drugpo.2008.10.003
29.
McNeelyJWangSSRostam AbadiY, et al. Addiction Consultation Services for opioid use disorder treatment initiation and engagement: a randomized clinical trial. JAMA Intern Med. 2024;184(9):1106-1115. doi:10.1001/jamainternmed.2024.3422
30.
BourgoisPHolmesSMSueKQuesadaJ.Structural vulnerability: operationalizing the concept to address health disparities in clinical care. Acad Med. 2017;92(3):299-307. doi:10.1097/ACM.0000000000001294
31.
QuesadaJHartLKBourgoisP.Structural vulnerability and health: Latino migrant laborers in the United States. Med Anthropol. 2011;30(4):339-362. doi:10.1080/01459740.2011.576725
32.
FoxR. Medical uncertainty revisited. In: AlbrechtGLFitzpatrickRScrimshawS, eds. Handbook of Social Studies in Health and Medicine. Sage Publications; 2000:409-425.
33.
GordonDR. Tenacious assumptions of western medicine. In: LockMGordonDR, eds. Biomedicine Reexamined. Kluwer Academic Publishers; 1988:19-56.
TongASainsburyPCraigJ.Consolidated Criteria for Reporting Qualitative Research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349-357. doi:10.1093/intqhc/mzm042
36.
DamschroderLJAronDCKeithREKirshSRAlexanderJALoweryJC.Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. doi:10.1186/1748-5908-4-50
37.
StraussACorbinJ.Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. 2nd ed.Sage Publications, Inc; 1998.
BowenGA.Grounded theory and sensitizing concepts. Int J Qual Methods. 2006;5(3):12-23. doi:10.1177/160940690600500304
40.
BuchmanDZHoAIllesJ.You present like a drug addict: patient and clinician perspectives on trust and trustworthiness in chronic pain management. Pain Med. 2016;17(8):1394-406. doi:10.1093/pm/pnv083
41.
McNeilRSmallWWoodEKerrT.Hospitals as a “risk environment”: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Soc Sci Med. 2014;105:59-66. doi:10.1016/j.socscimed.2014.01.010
42.
GryczynskiJNordeckCDWelshCMitchellSGO’GradyKESchwartzRP.Preventing hospital readmission for patients with comorbid substance use disorder: a randomized trial. Ann Intern Med. 2021;174(7):899-909. doi:10.7326/M20-5475
43.
KrawczykNRiveraBDChangJELindenfeldZFranzB.Initiatives to support the transition of patients with substance use disorders from acute care to community-based services among a national sample of nonprofit hospitals. J Addict Med. 2024;18(2):115-121. doi:10.1097/ADM.0000000000001250
NYC Office of Chief Medical Examiner and NYC DOHMH Bureau of Vital Statistics. Unintentional Drug Poisoning (Overdose) Deaths in New York City in 2020. New York City Department of Health and Mental Hygiene: Epi Data Brief (#129); November 2021.
46.
LagisettyPARossRBohnertAClayMMaustDT.Buprenorphine treatment divide by race/ethnicity and payment. JAMA Psychiatry. 2019;76(9):979-981. doi:10.1001/jamapsychiatry.2019.0876
47.
LindsayARWinkelmanTNABartGRhodesMTShearerRD.Hospital addiction medicine consultation service orders and outcomes by patient race and ethnicity in an urban, safety-net hospital. J Gen Intern Med. 2023;39(2):168-175. doi:10.1007/s11606-023-08356-4
48.
Rostam-AbadiYMcNeelyJTarpeyT, et al. Medication for opioid use disorder for hospitalized patients at six New York City public hospitals with an addiction consult service. J Addict Med. 2025;19(5):557-564. doi:10.1097/ADM.0000000000001450
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
